Charles Kunsch
Direttore/Membro del Consiglio presso CAPTOR THERAPEUTICS SPOLKA AKCYJNA
Posizioni attive di Charles Kunsch
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| CAPTOR THERAPEUTICS SPOLKA AKCYJNA | Direttore/Membro del Consiglio | 01/04/2024 | - |
Kojin Therapeutics, Inc.
 Kojin Therapeutics, Inc. BiotechnologyHealth Technology Kojin Therapeutics, Inc. operates as a small-molecule therapeutics company. It focuses on translating deep biological insight into the plasticity of human cell states to develop therapeutics for cancer, fibrosis, ischemia and immune modulation. The company was founded by Benjamin Cravatt, Stephanie K. Dougan and Stuart L.Schreiber and is headquartered in the United States. | Direttore/Membro del Consiglio | 01/09/2021 | - |
Aquinnah Pharmaceuticals, Inc.
 Aquinnah Pharmaceuticals, Inc. BiotechnologyHealth Technology Aquinnah Pharmaceuticals, Inc. restores the health of people with ALS, Alzheimer?s disease and other neurodegenerative diseases. The company was founded by Glenn Larsen and Ben Wolozin in 2014 and is headquartered in Cambridge, MA. | Direttore/Membro del Consiglio | 01/04/2017 | - |
| Massachusetts Biomedical Initiatives | Direttore/Membro del Consiglio | 01/10/2020 | - |
Accent Therapeutics, Inc.
 Accent Therapeutics, Inc. BiotechnologyHealth Technology Accent Therapeutics, Inc. operates as a biopharmaceutical company which develops treatments for cancer patients. The company was founded by Howard Y. Chang, Chuan He and Robert A. Copeland in September 2017 and is headquartered in Lexington, MA. | Direttore/Membro del Consiglio | 01/07/2021 | - |
Dg Medicines
 Dg Medicines Pharmaceuticals: MajorHealth Technology Dg Medicines develops medicines and products in various therapeutic areas. | Direttore/Membro del Consiglio | 01/12/2021 | - |
Endlyz Therapeutics, Inc.
 Endlyz Therapeutics, Inc. BiotechnologyHealth Technology Endlyz Therapeutics, Inc. is an American company that operates in the biotechnology industry. | Direttore/Membro del Consiglio | 01/08/2021 | - |
Penn State Research Foundation
 Penn State Research Foundation Miscellaneous Commercial ServicesCommercial Services Penn State Research Foundation provides scientific research services aimed at improving human conditions. The non-profit company is based in University Park, PA. | Direttore/Membro del Consiglio | - | - |
Storia della carriera di Charles Kunsch
Precedenti posizioni note di Charles Kunsch
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
AbbVie Ventures LLC
 AbbVie Ventures LLC Investment ManagersFinance AbbVie Ventures LLC (AbbVie Ventures) is a venture capital firm, a subsidiary of AbbVie, Inc. founded in 2009. The firm is headquartered in North Chicago, Illinois. | Investitore di Private Equity | 01/09/2013 | 01/10/2023 |
| ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░ ░░░░░░ ░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
Formazione di Charles Kunsch
| Drexel University | Undergraduate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 11 |
| Polonia | 2 |
Posizioni
| Director/Board Member | 8 |
| Private Equity Investor | 2 |
| Undergraduate Degree | 1 |
Settori
| Health Technology | 8 |
| Finance | 2 |
| Consumer Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| CAPTOR THERAPEUTICS SPOLKA AKCYJNA | Health Technology |
| Aziende private | 9 |
|---|---|
AbbVie Ventures LLC
AbbVie Ventures LLC Investment ManagersFinance AbbVie Ventures LLC (AbbVie Ventures) is a venture capital firm, a subsidiary of AbbVie, Inc. founded in 2009. The firm is headquartered in North Chicago, Illinois. | Finance |
Kojin Therapeutics, Inc.
Kojin Therapeutics, Inc. BiotechnologyHealth Technology Kojin Therapeutics, Inc. operates as a small-molecule therapeutics company. It focuses on translating deep biological insight into the plasticity of human cell states to develop therapeutics for cancer, fibrosis, ischemia and immune modulation. The company was founded by Benjamin Cravatt, Stephanie K. Dougan and Stuart L.Schreiber and is headquartered in the United States. | Health Technology |
AtheroGenics, Inc.
 AtheroGenics, Inc. Pharmaceuticals: MajorHealth Technology AtheroGenics is a pharmaceutical company focused on the discovery, development and commercialization of novel drugs for the treatment of chronic inflammatory diseases, such as atherosclerosis, asthma and arthritis. | Health Technology |
Aquinnah Pharmaceuticals, Inc.
Aquinnah Pharmaceuticals, Inc. BiotechnologyHealth Technology Aquinnah Pharmaceuticals, Inc. restores the health of people with ALS, Alzheimer?s disease and other neurodegenerative diseases. The company was founded by Glenn Larsen and Ben Wolozin in 2014 and is headquartered in Cambridge, MA. | Health Technology |
| Massachusetts Biomedical Initiatives | |
Accent Therapeutics, Inc.
Accent Therapeutics, Inc. BiotechnologyHealth Technology Accent Therapeutics, Inc. operates as a biopharmaceutical company which develops treatments for cancer patients. The company was founded by Howard Y. Chang, Chuan He and Robert A. Copeland in September 2017 and is headquartered in Lexington, MA. | Health Technology |
Dg Medicines
Dg Medicines Pharmaceuticals: MajorHealth Technology Dg Medicines develops medicines and products in various therapeutic areas. | Health Technology |
Endlyz Therapeutics, Inc.
Endlyz Therapeutics, Inc. BiotechnologyHealth Technology Endlyz Therapeutics, Inc. is an American company that operates in the biotechnology industry. | Health Technology |
Penn State Research Foundation
Penn State Research Foundation Miscellaneous Commercial ServicesCommercial Services Penn State Research Foundation provides scientific research services aimed at improving human conditions. The non-profit company is based in University Park, PA. | Commercial Services |
- Borsa valori
- Insiders
- Charles Kunsch
- Esperienza
